Turning Point Benefit Group’s MetLife MET Stock Holding History

Turning Point Benefit Group’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41	Closed	-$3.24K	–	510
2025 Q4	$3.24K	Buy	+41	New	+$3.25K	﹤0.01%	366

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Turning Point Benefit Group's MET Position: Q1 2026 in Review

Turning Point Benefit Group sold out of MetLife (MET) in Q1 2026, closing a stake of 41 shares — an estimated $3.24K sold.

Turning Point Benefit Group first reported a position in MET in Q4 2025 and held it in 1 quarter. The position peaked at $3.24K in Q4 2025. 1,384 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Turning Point Benefit Group reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 41 MetLife shares in Q1 2026, an estimated $3.24K.
Turning Point Benefit Group first reported a position in MetLife in Q4 2025 and held it in 1 quarter.
Turning Point Benefit Group's MetLife position peaked at $3.24K in Q4 2025.
1,384 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.